Solara Active Pharma Sciences Share Price

NSE
SOLARA •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Solara Active Pharma Sciences Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
26.16% Fall from 52W High
-13
TTM PE Ratio
Negative PE TTM
-4.9
Price to Book Ratio
Below industry Median
2.8
Dividend yield 1yr %
0
TTM PEG Ratio
0

Solara Active Pharma Sciences Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Solara Active Pharma Sciences Ltd Quarterly Revenue

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
346.95 Cr
363.49 Cr
299.43 Cr
248.73 Cr
425.24 Cr

Solara Active Pharma Sciences Ltd Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
1294.29 Cr
1466.36 Cr
1288.36 Cr
1645.65 Cr
1349.27 Cr

Solara Active Pharma Sciences Ltd Quarterly Net Profit/Loss

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
8.01 Cr
-13.46 Cr
-255.45 Cr
-275.34 Cr
-17.06 Cr

Solara Active Pharma Sciences Ltd Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
-566.96 Cr
-22.25 Cr
-58.29 Cr
221.35 Cr
114.52 Cr

Solara Active Pharma Sciences Ltd shareholding Pattern

Promoter
37.3%
Foreign Institutions
14.2%
Mutual Funds
1.3%
Domestic Institutions
3.4%
Public
45.1%
Promoter
37.3%
Foreign Institutions
14%
Mutual Funds
1.3%
Domestic Institutions
2.8%
Public
45.9%
Promoter
30.5%
Foreign Institutions
15.8%
Mutual Funds
1.7%
Domestic Institutions
3%
Public
50.7%
Promoter
30.5%
Foreign Institutions
16.6%
Mutual Funds
1.7%
Domestic Institutions
1.8%
Public
51.1%
Promoter
37.2%
Foreign Institutions
17.9%
Mutual Funds
1.8%
Domestic Institutions
1.7%
Public
43.2%
Promoter
39.3%
Foreign Institutions
18.7%
Mutual Funds
1.7%
Domestic Institutions
1.8%
Public
40.2%

Solara Active Pharma Sciences Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
14
5Day EMA
714.50
10Day EMA
734.70
12Day EMA
740.80
20Day EMA
755.80
26Day EMA
761.40
50Day EMA
762.20
100Day EMA
723.40
200Day EMA
637.20
5Day SMA
714.90
10Day SMA
737.30
20Day SMA
777.40
30Day SMA
775.00
50Day SMA
776.00
100Day SMA
745.40
150Day SMA
665.10
200Day SMA
603.90
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
175874 Rs
290401 Rs
Week Rs
109833 Rs
171972 Rs
Month Rs
90729 Rs
146742 Rs
Resistance & Support
696.65
Pivot
Resistance
First Resistance
715.05
Second Resistance
743.35
Third Resistance
761.75
Support
First Support
668.35
Second support
649.95
Third Support
621.65
Relative Strength Index
31
Money Flow Index
0.00
MACD
-20.64
MACD Signal
-9.53
Average True Range
33.72
Average Directional Index
18.44
Rate of Change (21)
-9.81
Rate of Change (125)
51.75

Solara Active Pharma Sciences Ltd Company background

Founded in: 2017
Managing director: Poorvank Purohit
Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs). The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two RD Centres in Chennai and Bengaluru. The Company offer rich basket of niche highvalue products for global markets. The Company has developed 80+ commercial APIs predominantly in anthelmintic, antimalarias, antiinfective, neuromuscular insomnia and antipsychotic hyperkalemia segments, among others. It also reinforce entry barriers to competition and build strong intrinsic value through market specific launches. Apart from this, the Solara Active has two research and development units in Bengaluru and Chennai equipped with stateoftheart facilities and a pipeline of 25+ products, at different stages of development. These drugs primarily deal with anthelmintic, antimalarias, beta blockers, muscle relaxants, novel oral anticoagulants, antiinfective and other niche segments.The Companys manufacturing facilities enjoy regulatory approvals from the United States Food and Drug Administration (USFDA) European Directorate for the Quality of Medicines (EDQM) Korea Food Drug Administration (KFDA) South Korea Euro Zone Good Manufacturing Practice (EUGMP) Danish, World Health Organization (WHO) Geneva Medicines and Healthcare products Regulatory Agency (MHRA) Federal Commission for the Protection against Sanitary Risk (Cofepris) Mexico Therapeutic Goods Administration (TGA) Australia Pharmaceuticals and Medical Devices Agency (PMDA) Japan.The Company acquired 100% of the equity shares of Strides Chemicals Private Limited and made it the wholly owned subsidiary of the Company effective from September 1, 2018. During the year 201819, the Companys wholly owned subsidiary Strides Chemicals Private Limited amalgamated with the Company on December 20, 2019 and the merger was given effect in February, 2020. The Companys new Greenfield plant situated at SEZ unit, Plot No.:3B,3C,3D, Part 2 and 2A1, APIIC APSEZ, Atchutapuram Village, Rambilli Mandal, Visakhapatnam 531011, Andhra Pradesh, commenced commercial production in 2021.The Company acquired 487000 additional stake in Sequent Penems Private Limited, subsidiary company and subsequently Sequent Pharma became the wholly owned subsidiary of Company effective from April 27, 2021. In 2024, the Company sold its entire shareholding in Sequent Penems Private Limited to Symbio Generrics India Private Limited and Sequent Penems Private Limited ceased to be asubsidiary of the Company with effect from April 25, 2024..
Read More

Solara Active Pharma Sciences Ltd FAQs

Solara Active Pharma Sciences Ltd shares are currently priced at 651.9 on NSE and 652.75 on BSE as of 12/20/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Solara Active Pharma Sciences Ltd [SOLARA] share was 114.99. The Solara Active Pharma Sciences Ltd [SOLARA] share hit a 1-year low of Rs. 292.62 and a 1-year high of Rs. 882.8.

The market cap of Solara Active Pharma Sciences Ltd is Rs. 2994.14 Cr. as of 12/20/2024 12:00:00 AM.

The PE ratios of Solara Active Pharma Sciences Ltd is 0 as of 12/20/2024 12:00:00 AM.

The PB ratios of Solara Active Pharma Sciences Ltd is 2.27 as of 12/20/2024 12:00:00 AM

The Mutual Fund Shareholding was 1.28% at the end of 12/20/2024 12:00:00 AM.

You can easily buy Solara Active Pharma Sciences Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -